COPE

Diabetic Eye Disease - Volume 2, Number 1

This activity is supported by an educational grant from Regeneron Pharmaceuticals, Inc.

Author(s)/Faculty: Reecha Kampani, OD; Rishi P. Singh, MD; Theodore Leng, MD, MS; Sherrol A. Reynolds, OD, FAAO; Ankoor R. Shah, MD; Diana L. Shechtman, OD, FAAO
Source: Healio - Optometry Education Lab
Type: MonographArticles/Items: 5
Release Date: 9/1/2016Expiration Date: 9/1/2017
Credit Type: COPENumber of Credits: 1
Cost: FreeProvider: Purdue U
Diabetic retinopathy (DR) is a major cause of blindness among American adults aged 40 years and older. The prevalence of DR in this population is increasing; it currently affects over 4 million people, and it is projected that this figure will rise to 6 million people by the year 2020. Data show that early treatment of diabetic eye disease offers the best long-term outcomes and reduces risk of progression, underscoring the importance of understanding the American Optometric Association guidelines for assessment and referral of patients with diabetes. Optometrists have a variety of roles to play in DR management, including performing visual acuity tests, early detection of DR using dilated ophthalmoscopy and other imaging modalities, monitoring disease progression, providing timely follow-up examinations and management, making referrals for concurrent care when indicated, and educating the patient. In this COPE accredited publication series, leading clinicians will discuss the clinical features of diabetic retinopathy, review effective screening techniques for diabetic eye diseases, as well as review evidence-based guidelines for the management, follow-up, and referral for patients with diabetic eye diseases.

CE Information

page 1 of 8